Designing Metabolic Pathways for Drug Production
Author Information
Author(s): Pablo Carbonell, Anne-Gaëlle Planson, Davide Fichera, Jean-Loup Faulon
Primary Institution: iSSB, Institute of Systems and Synthetic Biology, University of Evry
Hypothesis
Can a retrosynthetic approach improve the design of metabolic pathways for therapeutic production?
Conclusion
The study presents a unified framework for designing industrial microorganisms capable of producing therapeutic compounds efficiently.
Supporting Evidence
- The method integrates various techniques for designing heterologous biosynthetic pathways.
- It allows for the flexible design of microorganisms for on-demand production of chemicals.
- The approach addresses the complexity of metabolic pathway design through molecular signatures.
Takeaway
This research helps scientists create better ways to make medicines using tiny living things by figuring out the best paths for chemical reactions.
Methodology
The study uses a retrosynthetic approach to design metabolic pathways, employing molecular signatures to represent compounds and reactions.
Limitations
The complexity of enumerating all feasible biosynthetic pathways can lead to combinatorial explosion.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website